Press Releases about Pfizer![]() ![]() ![]() From Pfizer Inc.
Via Business Wire
![]() Via MarketBeat
Topics
Artificial Intelligence
![]() Via MarketBeat
Topics
Initial Public Offering
![]() ![]() ![]() ![]() ![]()
Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
February 22, 2023
From Pfizer Inc.
Via Business Wire
![]() ![]() Via SBWire
![]() ![]() ![]() ![]()
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
February 10, 2023
From Pfizer Inc.
Via Business Wire
Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030
February 09, 2023
Via SBWire
![]()
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 09, 2023
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|